Scarica l'app Stockscreener
2.99
1.97%
-0.06
Dopo l'orario di chiusura:
2.99
Precedente Chiudi:
$3.05
Aprire:
$3.0951
Volume 24 ore:
31,483
Relative Volume:
0.07
Capitalizzazione di mercato:
$9.10M
Reddito:
-
Utile/perdita netta:
$2.81M
Rapporto P/E:
-0.2084
EPS:
-14.3497
Flusso di cassa netto:
$7.14M
1 W Prestazione:
-5.97%
1M Prestazione:
-1.32%
6M Prestazione:
-21.93%
1 anno Prestazione:
-36.25%
Intervallo 1D:
$2.99
$3.10
Intervallo di 1 settimana:
$2.96
$3.2328
Portata 52W:
$2.51
$4.80
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Nome
Kiora Pharmaceuticals Inc
Settore
Industria
Telefono
781-788-8869
Indirizzo
332 ENCINITAS BOULEVARD, ENCINITAS
Confronta KPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
2.99 | 9.28M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Kiora Pharmaceuticals Inc Borsa (KPRX) Ultime notizie
What is the risk reward ratio of investing in Kiora Pharmaceuticals Inc. stockMaximize portfolio value with smart investment plans - jammulinksnews.com
What are the latest earnings results for Kiora Pharmaceuticals Inc.Phenomenal trading returns - jammulinksnews.com
Kiora Pharmaceuticals Inc. Stock Support and Resistance Levels You Should KnowFree Trading Group - Newser
Why Kiora Pharmaceuticals Inc. stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser
Can Kiora Pharmaceuticals Inc. stock recover from recent declineCapital Protected Stock Selections - Newser
Kiora Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveProfitable Yet Secure Picks - Newser
What makes Kiora Pharmaceuticals Inc. stock price move sharplyBreakout Momentum Alerts - Newser
Is Kiora Pharmaceuticals Inc. a good long term investmentDouble-digit growth - PrintWeekIndia
What drives Kiora Pharmaceuticals Inc. stock priceDynamic investment opportunities - Autocar Professional
What analysts say about Kiora Pharmaceuticals Inc. stockPhenomenal trading returns - PrintWeekIndia
Kiora Pharmaceuticals Secures US Patent for KIO-104 - Ophthalmology Times
Kiora Pharmaceuticals Inc. Stock Analysis and ForecastExtraordinary market timing - Autocar Professional
KPRX Receives Positive Outlook Following New U.S. Patent | KPRX Stock News - GuruFocus
Kiora Pharmaceuticals stock rises after receiving patent for KIO-104 - Investing.com India
Kiora Pharmaceuticals stock rises after receiving patent for KIO-104 By Investing.com - Investing.com Nigeria
Kiora Pharmaceuticals receives patent for ocular disease treatment By Investing.com - Investing.com South Africa
Kiora Pharmaceuticals receives patent for ocular disease treatment - Investing.com Australia
Kiora Secures Crucial Patent for Eye Disease Drug KIO-104 as Phase 2 Trial Advances - Stock Titan
Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know - MSN
Retinitis Pigmentosa Treatment Market Driven by Gene Therapy - openPR.com
How Kiora Pharmaceuticals Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser
Kiora Pharmaceuticals (NASDAQ:KPRX) Trading 1.8% Higher – Here’s Why - Defense World
Kiora Pharmaceuticals (NASDAQ:KPRX) Trading Down 0.3% – Here’s Why - Defense World
Kiora Pharmaceuticals and Senju Pharmaceutical partner on KIO-301 for retinal disease treatment in Asia - Ophthalmology Times
Kiora Pharmaceuticals Inc Azioni (KPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):